3-Substituted oxindole β3 agonists

Details 3-Substituted oxindole β3 agonists 3-Substituted oxindole β3 agonists

2007-04-17

2007-04-17

Owens, Amelia A. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S121000

Reexamination Certificate

active

10495085

ABSTRACT:
The present invention relates to a β3 adrenergic receptor agonist of Formula (I) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity

REFERENCES:
patent: 4234595 (1980-11-01), Kreighbaum et al.
patent: 4276304 (1981-06-01), Ikezaki et al.
patent: 4314943 (1982-02-01), Kreighbaum et al.
patent: 4826847 (1989-05-01), Michel et al.
patent: 5808080 (1998-09-01), Bell et al.
patent: 6011048 (2000-01-01), Mathvink et al.
patent: 6911463 (2005-06-01), Sall et al.
patent: 7071208 (2006-07-01), Bastian et al.
patent: 7087635 (2006-08-01), Sall et al.
patent: 2005/0080110 (2005-04-01), Sall et al.
patent: 2006/0142327 (2006-06-01), Bastian et al.
patent: 2006/0142328 (2006-06-01), Bastian et al.
patent: 2006/0142329 (2006-06-01), Bastian et al.
patent: 2830884 (1979-01-01), None
patent: 0 166 331 (1986-01-01), None
patent: 166331 (1986-01-01), None
patent: 221414 (1987-05-01), None
patent: 236624 (1987-09-01), None
patent: 611003 (1994-08-01), None
patent: 678511 (1995-10-01), None
patent: 764640 (1997-03-01), None
patent: 2001 633 (1979-02-01), None
patent: 1549945 (1979-08-01), None
patent: WO 95/29159 (1995-11-01), None
patent: WO 97/10825 (1997-03-01), None
patent: WO 97/46556 (1997-12-01), None
patent: WO 98/4526 (1998-02-01), None
patent: WO 98/9625 (1998-03-01), None
patent: WO 98/32753 (1998-07-01), None
patent: WO 00/40560 (2000-07-01), None
patent: WO 00/44721 (2000-08-01), None
patent: WO 01/7026 (2001-02-01), None
patent: WO 01/35947 (2001-05-01), None
patent: WO 01/36412 (2001-05-01), None
patent: WO 01/53298 (2001-07-01), None
patent: WO 02/6276 (2002-01-01), None
patent: WO 02/38543 (2002-05-01), None
patent: WO 03/16276 (2003-02-01), None
patent: WO 03/16307 (2003-02-01), None
Weber A E, et al;Bioorganic&Medicinal Chemistry Letters; 8(16):2111-2116, 1998.
Shuker A J, et al;Tetrahedron Letters; 38(35, Sep. 1, 1997; pp. 6149-6152.
Weber A E, et al; Bioorganic & Medicinal Chemistry Letters; 8(9):1101-1106, 1998.

Affiliated with

Also associated with

Rating

3-Substituted oxindole β3 agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-Substituted oxindole β3 agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Substituted oxindole β3 agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3793353